Corcept Therapeutics
CORT
#2161
Rank
C$11.84 B
Marketcap
C$112.39
Share price
-0.90%
Change (1 day)
48.26%
Change (1 year)

Earnings for Corcept Therapeutics (CORT)

Earnings in 2025 (TTM): C$91.68 Million

According to Corcept Therapeutics 's latest financial reports the company's current earnings are C$0.74 Billion. In 2024 the company made an earning of C$0.18 Billion, an increase over its 2023 earnings that were of C$0.14 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Corcept Therapeutics from 2003 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) C$91.68 M-51.43%
2024 C$0.18 B27.66%
2023 C$0.14 B-4.75%
2022 C$0.15 B-9.51%
2021 C$0.17 B-2.91%
2020 C$0.17 B14.87%
2019 C$0.15 B24.71%
2018 C$0.12 B69.32%
2017 C$72.85 M419.26%
2016 C$14.02 M-395.64%
2015 -C$4.75 Million-87.53%
2014 -C$38.07 Million-33.44%
2013 -C$57.2 Million
2011 -C$44.57 Million17.84%
2010 -C$37.82 Million35.5%
2009 -C$27.91 Million2.84%
2008 -C$27.14 Million60.81%
2007 -C$16.88 Million-52.14%
2006 -C$35.27 Million20.91%
2005 -C$29.17 Million31.87%
2004 -C$22.12 Million60.54%
2003 -C$13.78 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
C$44.65 B 49,305.23%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
C$11.07 B 12,150.66%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
C$22.63 B 24,939.65%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Eli Lilly
LLY
C$31.01 B 34,218.92%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
C$16.33 B 17,974.79%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
C$31.82 B 35,113.20%๐Ÿ‡บ๐Ÿ‡ธ USA
Esperion Therapeutics
ESPR
-C$37.83 Million-141.85%๐Ÿ‡บ๐Ÿ‡ธ USA
MannKind Corp
MNKD
C$42.42 M-53.05%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
C$0.93 B 935.92%๐Ÿ‡บ๐Ÿ‡ธ USA